Literature DB >> 34359639

Mouse Models in Meningioma Research: A Systematic Review.

Julien Boetto1,2, Matthieu Peyre2,3,4, Michel Kalamarides2,3,4.   

Abstract

Meningiomas are the most frequent primitive central nervous system tumors found in adults. Mouse models of cancer have been instrumental in understanding disease mechanisms and establishing preclinical drug testing. Various mouse models of meningioma have been developed over time, evolving in light of new discoveries in our comprehension of meningioma biology and with improvements in genetic engineering techniques. We reviewed all mouse models of meningioma described in the literature, including xenograft models (orthotopic or heterotopic) with human cell lines or patient derived tumors, and genetically engineered mouse models (GEMMs). Xenograft models provided useful tools for preclinical testing of a huge range of innovative drugs and therapeutic options, which are summarized in this review. GEMMs offer the possibility of mimicking human meningiomas at the histological, anatomical, and genetic level and have been invaluable in enabling tumorigenesis mechanisms, including initiation and progression, to be dissected. Currently, researchers have a range of different mouse models that can be used depending on the scientific question to be answered.

Entities:  

Keywords:  GEMM; meningioma; mouse model; xenograft

Year:  2021        PMID: 34359639     DOI: 10.3390/cancers13153712

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  3 in total

1.  Gene replacement therapy in a schwannoma mouse model of neurofibromatosis type 2.

Authors:  Shilpa Prabhakar; Roberta L Beauchamp; Pike See Cheah; Akiko Yoshinaga; Edwina Abou Haidar; Sevda Lule; Gayathri Mani; Katia Maalouf; Anat Stemmer-Rachamimov; David H Jung; D Bradley Welling; Marco Giovannini; Scott R Plotkin; Casey A Maguire; Vijaya Ramesh; Xandra O Breakefield
Journal:  Mol Ther Methods Clin Dev       Date:  2022-06-22       Impact factor: 5.849

Review 2.  Modeling Brain Tumors: A Perspective Overview of in vivo and Organoid Models.

Authors:  Francesco Antonica; Giuseppe Aiello; Alessia Soldano; Luana Abballe; Evelina Miele; Luca Tiberi
Journal:  Front Mol Neurosci       Date:  2022-05-30       Impact factor: 6.261

Review 3.  The Current Role of Peptide Receptor Radionuclide Therapy in Meningiomas.

Authors:  Christina-Katharina Fodi; Jens Schittenhelm; Jürgen Honegger; Salvador Guillermo Castaneda-Vega; Felix Behling
Journal:  J Clin Med       Date:  2022-04-23       Impact factor: 4.964

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.